Shopping Cart 0
Cart Subtotal
USD 0

Singapore Contract Research Outsourcing Market Outlook to 2022 - by Phase I, Phase II, Phase III, Phase IV, Pre-Clinical Market, Data Management, Biostatistics, Central Laboratory Services, Pharmacovigilance, Bioanalytics and HEOR

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: Yes
Copy Option: No
Deliverable Format : PDF Via Email

Single User License
USD 2000

Access to Printed Report; No Soft Copy
Print Option: N/A
Copy Option: N/A
Deliverable Format : Printed Publication/ Book by Post

Hard Copy License
USD 3200

Multiple Users within the Company/ Enterprise
Print Option: Yes
Copy Option: Yes
Deliverable Format : Excel, PDF Via Email

Corporate User License
USD 4000
  • Details
  • Table Of Content
  • Licence Rights
  • Section Purchase
  • Products and Companies

Details

The report titled "Singapore Contract Research Organization Market Outlook to 2022 - by Phase I, Phase II, Phase III, Phase IV, Pre-Clinical Market, Data Management, Biostatistics, Central Laboratory Services, Pharmacovigilance, Bioanalytics and HEOR" covers aspects such as CRO market segment (by Phase I, Phase II, Phase III, Phase IV, Pre-Clinical Market, Data Management, Biostatistics, Central Laboratory Services, Pharmacovigilance, Bioanalytics and HEOR), by Number of Clinical Trials, by Therapeutic Area (Oncology, Clinical Pharmacology, gastroenterology & hepatology, Dermatology, cardiology, diagnostic imaging, infectious diseases, ophthalmology and others), and covering competitive landscape of major CRO companies including Singapore Clinical Research Institute (SCRI), Phoenix Pharma Central Services (S) Pte Ltd, Maccine Pte Ltd, Covance (Asia) Pte Ltd, Quintiles East Asia Pte Ltd, EPS Global Research Pte Ltd., ICON Clinical Research Pte Ltd, PPD Development (S) Pte Ltd, PAREXEL International Corporation, PRA Singapore, Syneos Health, Novotech, and SGS. The report concludes with market projection for future and analyst recommendations highlighting the major opportunities and cautions.

Singapore CRO Market
Singapore CRO market has inclined at positive CAGR during 2013-2017. The market is majorly driven by patent expiration of main revenue-generating drugs, competition from the generic versions of branded drugs, and increasing research and development costs which have pushed pharmaceuticals manufacturers to look for strategies to cut costs and speed up the R&D processes. The manufacturers struggle to renew their pipelines while facing the challenges of efficient drug discovery which has propelled growth in the contract research outsourcing industry in Singapore. Further, the market is supported by best in class infrastructure for research, highly skilled workforce, Strong intellectual property (IP) and legal infrastructure and government support.

Singapore CRO Market Segmentation
The CRO market includes revenue generated from Phase I, II, II, IV clinical trials, Pre-clinical market, data management, biostatistics, and central laboratory services, Pharmacovigilance, Bioanalytics and HEOR. Growing emphasis on translational research within pharmaceutical R&D due to the government’s commitment to scientific research has propelled the growth of pre-clinical market in Singapore. Early phase clinical trials such as Phase I and Phase II are rising rapidly owing to its small patient pool, strong legal and political system, world-class infrastructure and connectivity, and access to talents. Other services such as Pharmacovigilance has witnessed increase in revenue as their scope expanded from just addressing ADR (Adverse Drug Reaction) to risk management plans and also because it also complies with local and global regulations. Bioanalytics is growing, as high cost and risk has led pharmaceutical companies to outsource more of pre-clinical and early phase development services.
The oncology segment has accounted for more than half of the clinical trials in 2015. Major factor driving the oncology segment include rising cases of cancer, availability of government funding for research purposes, and growing expertise for cancer by CROs. Other major therapeutic segments include clinical pharmacology, gastroenterology & hepatology, cardiology, diagnostic imaging, infectious diseases, ophthalmology and others.

Singapore CRO Market Competition Overview

CRO market in Singapore is dominated by MNCs that are capitalizing on the increasing government support for clinical research and foreign investment. The number of clinical trials increased due to establishment of more clinical trial units and more patient participation that gives them the opportunity to access innovative experimental treatments that are not yet available in the market. The market is concentrated with top 10 companies occupying more than half of the overall market revenue. Major competition parameters include service portfolio and therapeutic areas covered by the Contract Research organization

Singapore CRO Market Future Potential
Singapore CRO market is expected to grow at a positive CAGR during 2018-2022. The two most significant market growth drivers are the reduction of drug lag and cost. Other growth drivers such as vendor consolidation and increased outsourcing penetration will further augment the CRO market in Singapore.

Key Topics Covered in the Report:

  • Singapore CRO Market Size, 2013-2017
  • Singapore Phase I, Phase II, Phase II, Phase IV, Data Management, Pre-Clinical, Biostatistics, Central Laboratory Services, Pharmacovigilance, Bioanalytics, and HEOR Market Size, 2013-2017
  • Singapore CRO Market Segmentation(by Major Therapeutic Segments and by Phase of Clinical Trial)
  • Trends and Developments in Singapore CRO Market
  • Government Initiatives, Rules and Regulations in Singapore CRO Market
  • Singapore CRO Market Competitive Landscape
  • Singapore CRO Future Outlook and Projections, 2018-2022
  • Value Chain in Singapore CRO Industry
READ MORE

Table Of Content

Scope

1. Research Methodology

1.1. Market Definitions
1.2. Abbreviations
1.3. Consolidated Research Approach
1.4. Variables (Dependent and Independent)
1.5. Singapore Hospital Market Correlation Matrix
1.6. Singapore Hospital Market Regression Matrix

2. Singapore Contract Research Organization Market - Executive Summary

3. Singapore Healthcare Ecosystem

4. Singapore Healthcare System

5. Singapore Healthcare Key Metrics

6. Comparative Analysis with Other Asian Countries

7. Singapore Contract Research Organization Market: Overview and Market Size- 2013-2017

8. Singapore Contract Research Organization Market Segmentation

9. Singapore Contract Research Organization Market - Growth Drivers

10. Singapore Contract Research Organization Market - Government Regulations

10.1. Government Regulations for Clinical Trials of Therapeutic Products
10.2. Government Regulations for Clinical Trials of Medicinal Products

11. Value Chain in Contract Research Organization

11.1. Value Chain in Contract Research Organization: Challenges

12. CRO Market Competitive Landscape

12.1. CRO Market Competition Analysis
12.2. Singapore Clinical Research Institute (SCRI)
12.3. Competition Matrix for Major Players in Singapore CRO Market

13. Singapore CRO Market Future Outlook and Projections, 2018-2022

14. Disclaimer


List Of Figure

Figure 2-1: Singapore Contract Research Organization Market Size by Revenue in USD Million, 2013, 2015 and 2017
Figure 2-2: Singapore Contract Research Organization Market Segmentation by Therapeutic Area, 2015
Figure 2-3: Singapore Contract Research Organization Market Segmentation by Phase on the Basis of Number of Clinical Trials, 2015
Figure 2-4: Singapore Contract Research Organization Market Size on the Basis of Number of Clinical Trials, 2011, 2013 and 2015
Figure 4-1: Singapore Healthcare System
Figure 5-1: Top Causes of Death in Singapore, 2016
Figure 7-1: Singapore Contract Research Organization Market Size on the Basis of Revenue in USD Million and Growth Rate in Percentage (%), 2013-2017
Figure 7-2: Singapore Contract Research Organization Market Size on the Basis of Number of Clinical Trials, 2011-2015
Figure 7-3: Singapore CRO Phase I Market Size on the Basis of Revenue in USD Million, 2013-2017
Figure 7-4: Singapore CRO Phase II Market Size on the Basis of Revenue in USD Million, 2013-2017
Figure 7-5: Singapore CRO Phase III Market Size on the Basis of Revenue in USD Million, 2013-2017
Figure 7-6: Singapore CRO Phase IV Market Size on the Basis of Revenue in USD Million, 2013-2017
Figure 7-7: Singapore CRO Pre-Clinical Market Size on the Basis of Revenue in USD Million, 2013-2017
Figure 7-8: Singapore CRO Data Management Market Size on the Basis of Revenue in USD Million, 2013-2017
Figure 7-9: Singapore CRO Biostatistics Market Size on the Basis of Revenue in USD Million, 2013-2017
Figure 7-10: Singapore CRO Central Laboratory Services Market Size on the Basis of Revenue in USD Million, 2013-2017
Figure 7-11: Singapore CRO Pharmacovigilance Market Size on the Basis of Revenue in USD Million, 2013-2017
Figure 7-12: Singapore CRO Bioanalytics Market Size on the Basis of Revenue in USD Million, 2013-2017
Figure 7-13: Singapore CRO HEOR Market Size on the Basis of Revenue in USD Million, 2013-2017
Figure 8-1: Singapore Contract Research Organization Market Segmentation by Therapeutic Area on the Basis of Number of Clinical Trials, 2015
Figure 8-2: Singapore Contract Research Organization Market Segmentation by Phase on the Basis of Number of Clinical Trials, 2015
Figure 10-1: Applicable Regulations for Clinical Trials of Therapeutic Products and Medicinal Products
Figure 10-2: Clinical Trial Authorization-Clinical Trial Notification (CTA-CTN) system
Figure 10-3: Difference Between Clinical Trial Authorization and Clinical Trial Notification System
Figure 11-1: Value Chain Analysis in Singapore CRO Market
Figure 13-1: Singapore CRO Market Future Outlook and Projections on the Basis of Revenue in USD Million, 2018-2022
Figure 13-2: Singapore CRO Phase II Market Size on the Basis of Revenue in USD Million, 2018-2022
Figure 13-3: Singapore CRO Phase I Market Size on the Basis of Revenue in USD Million, 2018-2022
Figure 13-4: Singapore CRO Phase III Market Size on the Basis of Revenue in USD Million, 2018-2022
Figure 13-5: Singapore CRO Phase IV Market Size on the Basis of Revenue in USD Million, 2018-2022
Figure 13-6: Singapore CRO Phase IV Market Size on the Basis of Revenue in USD Million, 2018-2022
Figure 13-7: Singapore CRO Data Management Market Size on the Basis of Revenue in USD Million, 2018-2022
Figure 13-8: Singapore CRO Biostatistics Market Size on the Basis of Revenue in USD Million, 2018-2022
Figure 13-9: Singapore CRO Pharmcovigilance Market Size on the Basis of Revenue in USD Million, 2018-2022
Figure 13-10: Singapore CRO Central Laboratory Services Market Size on the Basis of Revenue in USD Million, 2018-2022
Figure 13-11: Singapore CRO Bioanalytics Market Size on the Basis of Revenue in USD Million, 2018-2022


List Of Table

Table 1-1: Correlation Matrix for Singapore Hospital Market
Table 1-2: Regression Coefficient Output for Singapore Hospital Market
Table 5-1: Singapore Healthcare Market Key Metrics, 2017
Table 5-2: Singapore Healthcare Personnel, 2017
Table 5-3: Incidence/Prevalence of Major Diseases, 2016
Table 5-4: Number of Cases of Major Infectious Diseases in Singapore, 2012-2017
Table 6-1: Comparison of Singapore Healthcare Statistics with Vietnam, Malaysia, Indonesia, South Korea, India, China and Australia, 2016
Table 6-2: Comparison of Singapore Healthcare Statistics with Vietnam, Malaysia, Indonesia, South Korea, India, China and Australia, 2017
Table 11-1: Major Challenges in Singapore CRO Market Value Chain
Table 12-1: Competition Matrix for Major Companies in Singapore CRO Market
Table 12-2: Competitive landscape of Singapore Clinical Research Institute (SCRI) including Overview, Therapeutic Areas, Services, and Clinical Research Networks
Table 12-3: Competitive landscape of Singapore Clinical Research Institute (SCRI) including Recent Developments, Key projects and Future Strategy
Table 12-4: Number of Patients Enrolled in Clinical Trials and All Research Studies by SCRI, 2014-2016
Table 12-5: Key Collaborators and Funding Sources for SCRI in 2016
Table 12-6: Key Statistics for SCRI as of 2016
Table 12-7: Numbers of Ongoing and Completed Studies since 2008 by Therapeutic class
Table 12-8: Competition Matrix for Phoenix Pharma Central Services (S) Pte Ltd, Maccine Pte Ltd, Covance Pte Ltd, Quintiles East Asia Pte Ltd, EPS Global Research Pte Ltd., ICON Clinical Research Pte Ltd, PPD Development (S) Pte Ltd, PAREXEL International Corporation, Syneos Health, Novotech and SGS

Licence Rights

License Type Excel Only Single User Single User + Excel Hard Copy Corporate User License
User Sharing Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only. Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only. Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only. Access to Printed Report; No Soft Copy Multiple Users within the Company/ Enterprise
Print Option
Copy Option :Yes :No
Citation Yes (Not Publically; but to Private Parties within the company/ affiliate)
Deliverable Format :via Email :via Email ; :via Email Printed Publication/ Book by Post ; :via Email
Customization 20%
Analyst Time (Post Purchase Queries on Call/ Email)
Disclaimer : In no circumstance, the complete / part of the publication may be resold for monetary terms by the client or any other party related to the client or can be made available on third party website or on Google for general public view.

Section Purchase

To know more information on Purchase by Section, please send a mail to support@kenresearch.com

Products and Companies

Products

CRO market segment (by Phase I, Phase II, Phase III, Phase IV, Pre-Clinical Market, Data Management, Biostatistics, Central Laboratory Services, Pharmacovigilance, Bioanalytics and HEOR),by Number of Clinical Trials by Therapeutic Area (Oncology, Clinical Pharmacology, gastroenterology & hepatology, Dermatology, cardiology, diagnostic imaging, infectious diseases, ophthalmology and others)


Companies

Singapore Clinical Research Institute (SCRI), Phoenix Pharma Central Services (S) Pte Ltd, Maccine Pte Ltd, Covance (Asia) Pte Ltd, Quintiles East Asia Pte Ltd, EPS Global Research Pte Ltd., ICON Clinical Research Pte Ltd, PPD Development (S) Pte Ltd, PAREXEL International Corporation, PRA Singapore, Syneos Health, Novotech, and SGS

The report titled "Singapore Contract Research Organization Market Outlook to 2022 - by Phase I, Phase II, Phase III, Phase IV, Pre-Clinical Market, Data Management, Biostatistics, Central Laboratory Services, Pharmacovigilance, Bioanalytics and HEOR" covers aspects such as CRO market segment (by Phase I, Phase II, Phase III, Phase IV, Pre-Clinical Market, Data Management, Biostatistics, Central Laboratory Services, Pharmacovigilance, Bioanalytics and HEOR), by Number of Clinical Trials, by Therapeutic Area (Oncology, Clinical Pharmacology, gastroenterology & hepatology, Dermatology, cardiology, diagnostic imaging, infectious diseases, ophthalmology and others), and covering competitive landscape of major CRO companies including Singapore Clinical Research Institute (SCRI), Phoenix Pharma Central Services (S) Pte Ltd, Maccine Pte Ltd, Covance (Asia) Pte Ltd, Quintiles East Asia Pte Ltd, EPS Global Research Pte Ltd., ICON Clinical Research Pte Ltd, PPD Development (S) Pte Ltd, PAREXEL International Corporation, PRA Singapore, Syneos Health, Novotech, and SGS. The report concludes with market projection for future and analyst recommendations highlighting the major opportunities and cautions.

Singapore CRO Market
Singapore CRO market has inclined at positive CAGR during 2013-2017. The market is majorly driven by patent expiration of main revenue-generating drugs, competition from the generic versions of branded drugs, and increasing research and development costs which have pushed pharmaceuticals manufacturers to look for strategies to cut costs and speed up the R&D processes. The manufacturers struggle to renew their pipelines while facing the challenges of efficient drug discovery which has propelled growth in the contract research outsourcing industry in Singapore. Further, the market is supported by best in class infrastructure for research, highly skilled workforce, Strong intellectual property (IP) and legal infrastructure and government support.

Singapore CRO Market Segmentation
The CRO market includes revenue generated from Phase I, II, II, IV clinical trials, Pre-clinical market, data management, biostatistics, and central laboratory services, Pharmacovigilance, Bioanalytics and HEOR. Growing emphasis on translational research within pharmaceutical R&D due to the government’s commitment to scientific research has propelled the growth of pre-clinical market in Singapore. Early phase clinical trials such as Phase I and Phase II are rising rapidly owing to its small patient pool, strong legal and political system, world-class infrastructure and connectivity, and access to talents. Other services such as Pharmacovigilance has witnessed increase in revenue as their scope expanded from just addressing ADR (Adverse Drug Reaction) to risk management plans and also because it also complies with local and global regulations. Bioanalytics is growing, as high cost and risk has led pharmaceutical companies to outsource more of pre-clinical and early phase development services.
The oncology segment has accounted for more than half of the clinical trials in 2015. Major factor driving the oncology segment include rising cases of cancer, availability of government funding for research purposes, and growing expertise for cancer by CROs. Other major therapeutic segments include clinical pharmacology, gastroenterology & hepatology, cardiology, diagnostic imaging, infectious diseases, ophthalmology and others.

Singapore CRO Market Competition Overview

CRO market in Singapore is dominated by MNCs that are capitalizing on the increasing government support for clinical research and foreign investment. The number of clinical trials increased due to establishment of more clinical trial units and more patient participation that gives them the opportunity to access innovative experimental treatments that are not yet available in the market. The market is concentrated with top 10 companies occupying more than half of the overall market revenue. Major competition parameters include service portfolio and therapeutic areas covered by the Contract Research organization

Singapore CRO Market Future Potential
Singapore CRO market is expected to grow at a positive CAGR during 2018-2022. The two most significant market growth drivers are the reduction of drug lag and cost. Other growth drivers such as vendor consolidation and increased outsourcing penetration will further augment the CRO market in Singapore.

Key Topics Covered in the Report:

  • Singapore CRO Market Size, 2013-2017
  • Singapore Phase I, Phase II, Phase II, Phase IV, Data Management, Pre-Clinical, Biostatistics, Central Laboratory Services, Pharmacovigilance, Bioanalytics, and HEOR Market Size, 2013-2017
  • Singapore CRO Market Segmentation(by Major Therapeutic Segments and by Phase of Clinical Trial)
  • Trends and Developments in Singapore CRO Market
  • Government Initiatives, Rules and Regulations in Singapore CRO Market
  • Singapore CRO Market Competitive Landscape
  • Singapore CRO Future Outlook and Projections, 2018-2022
  • Value Chain in Singapore CRO Industry
READ MORE

Scope

1. Research Methodology

1.1. Market Definitions
1.2. Abbreviations
1.3. Consolidated Research Approach
1.4. Variables (Dependent and Independent)
1.5. Singapore Hospital Market Correlation Matrix
1.6. Singapore Hospital Market Regression Matrix

2. Singapore Contract Research Organization Market - Executive Summary

3. Singapore Healthcare Ecosystem

4. Singapore Healthcare System

5. Singapore Healthcare Key Metrics

6. Comparative Analysis with Other Asian Countries

7. Singapore Contract Research Organization Market: Overview and Market Size- 2013-2017

8. Singapore Contract Research Organization Market Segmentation

9. Singapore Contract Research Organization Market - Growth Drivers

10. Singapore Contract Research Organization Market - Government Regulations

10.1. Government Regulations for Clinical Trials of Therapeutic Products
10.2. Government Regulations for Clinical Trials of Medicinal Products

11. Value Chain in Contract Research Organization

11.1. Value Chain in Contract Research Organization: Challenges

12. CRO Market Competitive Landscape

12.1. CRO Market Competition Analysis
12.2. Singapore Clinical Research Institute (SCRI)
12.3. Competition Matrix for Major Players in Singapore CRO Market

13. Singapore CRO Market Future Outlook and Projections, 2018-2022

14. Disclaimer


List Of Figure

Figure 2-1: Singapore Contract Research Organization Market Size by Revenue in USD Million, 2013, 2015 and 2017
Figure 2-2: Singapore Contract Research Organization Market Segmentation by Therapeutic Area, 2015
Figure 2-3: Singapore Contract Research Organization Market Segmentation by Phase on the Basis of Number of Clinical Trials, 2015
Figure 2-4: Singapore Contract Research Organization Market Size on the Basis of Number of Clinical Trials, 2011, 2013 and 2015
Figure 4-1: Singapore Healthcare System
Figure 5-1: Top Causes of Death in Singapore, 2016
Figure 7-1: Singapore Contract Research Organization Market Size on the Basis of Revenue in USD Million and Growth Rate in Percentage (%), 2013-2017
Figure 7-2: Singapore Contract Research Organization Market Size on the Basis of Number of Clinical Trials, 2011-2015
Figure 7-3: Singapore CRO Phase I Market Size on the Basis of Revenue in USD Million, 2013-2017
Figure 7-4: Singapore CRO Phase II Market Size on the Basis of Revenue in USD Million, 2013-2017
Figure 7-5: Singapore CRO Phase III Market Size on the Basis of Revenue in USD Million, 2013-2017
Figure 7-6: Singapore CRO Phase IV Market Size on the Basis of Revenue in USD Million, 2013-2017
Figure 7-7: Singapore CRO Pre-Clinical Market Size on the Basis of Revenue in USD Million, 2013-2017
Figure 7-8: Singapore CRO Data Management Market Size on the Basis of Revenue in USD Million, 2013-2017
Figure 7-9: Singapore CRO Biostatistics Market Size on the Basis of Revenue in USD Million, 2013-2017
Figure 7-10: Singapore CRO Central Laboratory Services Market Size on the Basis of Revenue in USD Million, 2013-2017
Figure 7-11: Singapore CRO Pharmacovigilance Market Size on the Basis of Revenue in USD Million, 2013-2017
Figure 7-12: Singapore CRO Bioanalytics Market Size on the Basis of Revenue in USD Million, 2013-2017
Figure 7-13: Singapore CRO HEOR Market Size on the Basis of Revenue in USD Million, 2013-2017
Figure 8-1: Singapore Contract Research Organization Market Segmentation by Therapeutic Area on the Basis of Number of Clinical Trials, 2015
Figure 8-2: Singapore Contract Research Organization Market Segmentation by Phase on the Basis of Number of Clinical Trials, 2015
Figure 10-1: Applicable Regulations for Clinical Trials of Therapeutic Products and Medicinal Products
Figure 10-2: Clinical Trial Authorization-Clinical Trial Notification (CTA-CTN) system
Figure 10-3: Difference Between Clinical Trial Authorization and Clinical Trial Notification System
Figure 11-1: Value Chain Analysis in Singapore CRO Market
Figure 13-1: Singapore CRO Market Future Outlook and Projections on the Basis of Revenue in USD Million, 2018-2022
Figure 13-2: Singapore CRO Phase II Market Size on the Basis of Revenue in USD Million, 2018-2022
Figure 13-3: Singapore CRO Phase I Market Size on the Basis of Revenue in USD Million, 2018-2022
Figure 13-4: Singapore CRO Phase III Market Size on the Basis of Revenue in USD Million, 2018-2022
Figure 13-5: Singapore CRO Phase IV Market Size on the Basis of Revenue in USD Million, 2018-2022
Figure 13-6: Singapore CRO Phase IV Market Size on the Basis of Revenue in USD Million, 2018-2022
Figure 13-7: Singapore CRO Data Management Market Size on the Basis of Revenue in USD Million, 2018-2022
Figure 13-8: Singapore CRO Biostatistics Market Size on the Basis of Revenue in USD Million, 2018-2022
Figure 13-9: Singapore CRO Pharmcovigilance Market Size on the Basis of Revenue in USD Million, 2018-2022
Figure 13-10: Singapore CRO Central Laboratory Services Market Size on the Basis of Revenue in USD Million, 2018-2022
Figure 13-11: Singapore CRO Bioanalytics Market Size on the Basis of Revenue in USD Million, 2018-2022


List Of Table

Table 1-1: Correlation Matrix for Singapore Hospital Market
Table 1-2: Regression Coefficient Output for Singapore Hospital Market
Table 5-1: Singapore Healthcare Market Key Metrics, 2017
Table 5-2: Singapore Healthcare Personnel, 2017
Table 5-3: Incidence/Prevalence of Major Diseases, 2016
Table 5-4: Number of Cases of Major Infectious Diseases in Singapore, 2012-2017
Table 6-1: Comparison of Singapore Healthcare Statistics with Vietnam, Malaysia, Indonesia, South Korea, India, China and Australia, 2016
Table 6-2: Comparison of Singapore Healthcare Statistics with Vietnam, Malaysia, Indonesia, South Korea, India, China and Australia, 2017
Table 11-1: Major Challenges in Singapore CRO Market Value Chain
Table 12-1: Competition Matrix for Major Companies in Singapore CRO Market
Table 12-2: Competitive landscape of Singapore Clinical Research Institute (SCRI) including Overview, Therapeutic Areas, Services, and Clinical Research Networks
Table 12-3: Competitive landscape of Singapore Clinical Research Institute (SCRI) including Recent Developments, Key projects and Future Strategy
Table 12-4: Number of Patients Enrolled in Clinical Trials and All Research Studies by SCRI, 2014-2016
Table 12-5: Key Collaborators and Funding Sources for SCRI in 2016
Table 12-6: Key Statistics for SCRI as of 2016
Table 12-7: Numbers of Ongoing and Completed Studies since 2008 by Therapeutic class
Table 12-8: Competition Matrix for Phoenix Pharma Central Services (S) Pte Ltd, Maccine Pte Ltd, Covance Pte Ltd, Quintiles East Asia Pte Ltd, EPS Global Research Pte Ltd., ICON Clinical Research Pte Ltd, PPD Development (S) Pte Ltd, PAREXEL International Corporation, Syneos Health, Novotech and SGS

License Type Excel Only Single User Single User + Excel Hard Copy Corporate User License
User Sharing Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only. Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only. Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only. Access to Printed Report; No Soft Copy Multiple Users within the Company/ Enterprise
Print Option
Copy Option :Yes :No
Citation Yes (Not Publically; but to Private Parties within the company/ affiliate)
Deliverable Format :via Email :via Email ; :via Email Printed Publication/ Book by Post ; :via Email
Customization 20%
Analyst Time (Post Purchase Queries on Call/ Email)
Disclaimer : In no circumstance, the complete / part of the publication may be resold for monetary terms by the client or any other party related to the client or can be made available on third party website or on Google for general public view.
To know more information on Purchase by Section, please send a mail to support@kenresearch.com

Products

CRO market segment (by Phase I, Phase II, Phase III, Phase IV, Pre-Clinical Market, Data Management, Biostatistics, Central Laboratory Services, Pharmacovigilance, Bioanalytics and HEOR),by Number of Clinical Trials by Therapeutic Area (Oncology, Clinical Pharmacology, gastroenterology & hepatology, Dermatology, cardiology, diagnostic imaging, infectious diseases, ophthalmology and others)


Companies

Singapore Clinical Research Institute (SCRI), Phoenix Pharma Central Services (S) Pte Ltd, Maccine Pte Ltd, Covance (Asia) Pte Ltd, Quintiles East Asia Pte Ltd, EPS Global Research Pte Ltd., ICON Clinical Research Pte Ltd, PPD Development (S) Pte Ltd, PAREXEL International Corporation, PRA Singapore, Syneos Health, Novotech, and SGS